Fate Therapeutics (FATE) R&D/CAPEX US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
R&D/CAPEX, % | 1 187% | 2 547% | 425.1% | 901.0% | 2 331% | 4 269% | |||
Changes by years, y/y, % | -1 246pp | +1 360pp | -2 122pp | +476pp | +1 430pp | -0.9% |
Fate Therapeutics. R&D/CAPEX, %
Fate Therapeutics. R&D/CAPEX, changes, pp
Fate Therapeutics (FATE) R&D/CAPEX US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
R&D/CAPEX, % | 2 046% | 1 859% | 6 066% | 14 879% | 31 764% | 4 269% | ||
Changes by years, y/y, % | +1 330pp | +1 056pp | +5 146pp | +13 573pp | +29 718pp | |||
Changes by quarters, q/q, % | +740pp | -187pp | +4 208pp | +8 813pp | +16 885pp |